- Open-label study of a proprietary treatment program targeting type A gamma-aminobutyric acid receptor dysregulation in methamphetamine dependenceHarold C Urschel
The Urschel Recovery Science Institute, 8222 Douglas Ave, Suite 375, Dallas, TX 75225, USA
Mayo Clin Proc 82:1170-8. 2007....
- A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependenceHarold C Urschel
Research Across America, CNS Research Group, Dallas, TX, USA
J Psychopharmacol 25:254-62. 2011..Decreased methylamphetamine use was also observed, as measured by urine drug screens and self-reports...